The Journal of Immunology, Vol 143, Issue 3 833-837, Copyright © 1989 by American Association of Immunologists

ARTICLES

Platelet-derived growth factor and IL-1 interactions in rheumatoid arthritis. Regulation of synoviocyte proliferation, prostaglandin production, and collagenase transcription

GK Kumkumian, R Lafyatis, EF Remmers, JP Case, SJ Kim and RL Wilder
Arthritis and Rheumatism Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, MD 20892.

We show that platelet-derived growth factor (PDGF) and IL-1 interact in both a synergistic and antagonistic manner to regulate synovial fibroblast-like cells (synoviocytes) derived from patients with rheumatoid arthritis. PDGF and IL-1 operated synergistically in vitro to stimulate synoviocyte proliferation in the presence of indomethacin. However, when these same cells were treated with PDGF and IL-1 in the absence of indomethacin, IL-1 inhibited PDGF-stimulated synoviocyte proliferation. Moreover, exogenous PGE2, a PG known to be produced in response to IL-1, dramatically inhibited synoviocyte proliferation induced by PDGF. PDGF also acted synergistically to markedly increase production of PGE2 stimulated by IL-1. This is in contrast to the antagonistic effect PDGF had on IL-1-stimulated collagenase transcription. IL-1 stimulated collagenase transcription, but PDGF did not. It in fact inhibited IL-1 stimulation of collagenase gene expression. These data differ somewhat from those reported for dermal fibroblasts. Our data further indicate that the effects of cytokines vary from one cell type to another, even amongst "fibroblasts," and illustrate the complexity of cytokine regulation of rheumatoid synoviocyte function.

This article has been cited by other articles:

				M. MacGillivray, M. T. Herrera-Abreu, C.-W. Chow, C. Shek, Q. Wang, E. Vachon, G.-S. Feng, K. A. Siminovitch, C. A. G. McCulloch, and G. P. Downey The Protein Tyrosine Phosphatase SHP-2 Regulates Interleukin-1-induced ERK Activation in Fibroblasts J. Biol. Chem., July 11, 2003; 278(29): 27190 - 27198. [Abstract] [Full Text] [PDF]

				A. Solomon, M. Grueterich, D.-Q. Li, D. Meller, S.-B. Lee, and S. C. G. Tseng Overexpression of Insulin-like Growth Factor-Binding Protein-2 in Pterygium Body Fibroblasts Invest. Ophthalmol. Vis. Sci., February 1, 2003; 44(2): 573 - 580. [Abstract] [Full Text] [PDF]

				A. Solomon, D.-Q. Li, S.-B. Lee, and S. C. G. Tseng Regulation of Collagenase, Stromelysin, and Urokinase-Type Plasminogen Activator in Primary Pterygium Body Fibroblasts by Inflammatory Cytokines Invest. Ophthalmol. Vis. Sci., July 1, 2000; 41(8): 2154 - 2163. [Abstract] [Full Text]

				Z. Han, D. L. Boyle, K. R. Aupperle, B. Bennett, A. M. Manning, and G. S. Firestein Jun N-Terminal Kinase in Rheumatoid Arthritis J. Pharmacol. Exp. Ther., October 1, 1999; 291(1): 124 - 130. [Abstract] [Full Text]

				M. Sarkissian and R. Lafyatis Integrin Engagement Regulates Proliferation and Collagenase Expression of Rheumatoid Synovial Fibroblasts J. Immunol., February 1, 1999; 162(3): 1772 - 1779. [Abstract] [Full Text] [PDF]

				O. V. Kolomytkin, A. A. Marino, K. K. Sadasivan, R. E. Wolf, and J. A. Albright Intracellular signaling mechanisms of interleukin-1beta in synovial fibroblasts Am J Physiol Cell Physiol, January 1, 1999; 276(1): C9 - C15. [Abstract] [Full Text] [PDF]

				N. Mizushima, H. Kohsaka, and N. Miyasaka Ceramide, a mediator of interleukin 1, tumour necrosis factor alpha , as well as Fas receptor signalling, induces apoptosis of rheumatoid arthritis synovial cells Ann Rheum Dis, August 1, 1998; 57(8): 495 - 499. [Abstract] [Full Text]